Holdings (Monthly)
Guide ↗
Select Biotechnology Portfolio
· Fidelity Select Portfolios| # | Name | Ticker | Since | Shares | Shares Δ | Value | Val Δ% | % Port | Cat |
|---|---|---|---|---|---|---|---|---|---|
| 1 | UCB SA | N/A | Feb 2026 | 357,874 | NEW | $105.1M | — | 2.00% | EC |
| 2 | JAZZ PHARMACEUTICALS PLC | N/A | Feb 2026 | 410,452 | NEW | $97.1M | — | 1.84% | EC |
| 3 | ROIVANT SCIENCES LTD | N/A | Feb 2026 | 1,982,419 | NEW | $59.5M | — | 1.13% | EC |
| 4 | CELCUITY INC | 15102K100 | May 2026 | 375,600 | NEW | $49.9M | — | 0.95% | EC |
| 5 | GALDERMA GROUP AG | N/A | Feb 2026 | 168,890 | NEW | $35.7M | — | 0.68% | EC |
| 6 | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | N/A | Feb 2026 | 637,600 | NEW | $30.8M | — | 0.59% | EC |
| 7 | BIO AB HOLDINGS LLC | N/A | Feb 2026 | 1,954,526 | NEW | $21.3M | — | 0.41% | EC |
| 8 | VIATRIS INC | 92556V106 | May 2026 | 1,290,166 | NEW | $21.0M | — | 0.40% | EC |
| 9 | ZEALAND PHARMA A/S | N/A | Feb 2026 | 377,990 | NEW | $19.2M | — | 0.36% | EC |
| 10 | NEWAMSTERDAM PHARMA COMPANY NV | N/A | Feb 2026 | 523,700 | NEW | $17.6M | — | 0.33% | EC |
| 11 | BIOHAVEN LTD | N/A | Feb 2026 | 1,448,896 | NEW | $16.0M | — | 0.30% | EC |
| 12 | KAILERA THERAPEUTICS INC | 482931102 | May 2026 | 619,399 | NEW | $14.2M | — | 0.27% | EC |
| 13 | RELAY THERAPEUTICS INC | 75943R102 | May 2026 | 1,010,467 | NEW | $14.2M | — | 0.27% | EC |
| 14 | UNIQURE N.V. | N/A | Feb 2026 | 473,082 | NEW | $13.5M | — | 0.26% | EC |
| 15 | IDORSIA LTD | N/A | Feb 2026 | 2,174,283 | NEW | $12.4M | — | 0.24% | EC |
| 16 | TYRA BIOSCIENCES INC | 90240B106 | May 2026 | 337,000 | NEW | $11.3M | — | 0.21% | EC |
| 17 | HEMAB THERAPEUTICS HOLDINGS INC | 423494103 | May 2026 | 379,476 | NEW | $10.8M | — | 0.21% | EC |
| 18 | CITY THERAPEUTICS INC | N/A | Feb 2026 | 684,300 | NEW | $10.0M | — | 0.19% | EP |
| 19 | GUBRA A/S | N/A | Feb 2026 | 166,002 | NEW | $9.3M | — | 0.18% | EC |
| 20 | TRIVENI BIO INC | N/A | Feb 2026 | 7,167,431 | NEW | $8.7M | — | 0.17% | EP |
| 21 | BIO AB HOLDINGS LLC | N/A | Feb 2026 | 1,954,526 | NEW | $8.7M | — | 0.17% | EC |
| 22 | HANSA BIOPHARMA AB | N/A | Feb 2026 | 2,290,077 | NEW | $8.4M | — | 0.16% | EC |
| 23 | SENSORION SA | N/A | Feb 2026 | 17,132,230 | NEW | $8.0M | — | 0.15% | EC |
| 24 | CANDID THERAPEUTICS | N/A | Feb 2026 | 1,666,667 | NEW | $6.2M | — | 0.12% | EP |
| 25 | ODYSSEY THERAPEUTICS INC | 67613T104 | May 2026 | 339,500 | NEW | $5.8M | — | 0.11% | EC |
| 26 | CARDURION PHARMACEUTICALS INC | N/A | Feb 2026 | 1,020,908 | NEW | $5.6M | — | 0.11% | EP |
| 27 | CAMP4 THERAPEUTICS CORP | N/A | Feb 2026 | 1,226,606 | NEW | $5.4M | — | 0.10% | EC |
| 28 | PROTHENA CORP PLC | N/A | Feb 2026 | 495,517 | NEW | $5.0M | — | 0.10% | EC |
| 29 | ZENAS BIOPHARMA INC | N/A | Feb 2026 | 263,137 | NEW | $4.8M | — | 0.09% | EC |
| 30 | NEURONA THERAPEUTICS INC | N/A | Feb 2026 | 1,618,100 | NEW | $4.7M | — | 0.09% | EP |
| 31 | PHARVARIS BV | N/A | Feb 2026 | 147,914 | NEW | $4.5M | — | 0.08% | EC |
| 32 | SCORPION THERAPEUTICS INC | N/A | Feb 2026 | 5,166,448 | NEW | $4.3M | — | 0.08% | EC |
| 33 | SIONNA THERAPEUTICS INC | 829401108 | May 2026 | 80,900 | NEW | $3.5M | — | 0.07% | EC |
| 34 | PARABILIS MEDICINES INC | N/A | Feb 2026 | 491,600 | NEW | $3.4M | — | 0.06% | EP |
| 35 | CRESCENT BIOPHARMA INC | N/A | Feb 2026 | 149,142 | NEW | $3.1M | — | 0.06% | EC |
| 36 | TRIVENI BIO INC | N/A | Feb 2026 | 2,388,534 | NEW | $3.0M | — | 0.06% | EP |
| 37 | NATIONAL RESILIENCE INC | N/A | Feb 2026 | 732,064 | NEW | $2.5M | — | 0.05% | EP |
| 38 | CRESCENT BIOPHARMA INC | N/A | Feb 2026 | 113,421 | NEW | $2.3M | — | 0.04% | EC |
| 39 | MBX BIOSCIENCES INC | 55287L101 | May 2026 | 73,100 | NEW | $2.3M | — | 0.04% | EC |
| 40 | WAVE LIFE SCIENCES LTD | N/A | Feb 2026 | 344,940 | NEW | $2.3M | — | 0.04% | EC |
| 41 | GH RESEARCH PLC | N/A | Feb 2026 | 92,500 | NEW | $2.2M | — | 0.04% | EC |
| 42 | ZURA BIO LTD | N/A | Feb 2026 | 509,657 | NEW | $2.2M | — | 0.04% | EC |
| 43 | KARDIGAN INC | N/A | Feb 2026 | 93,611 | NEW | $2.0M | — | 0.04% | EP |
| 44 | CELLCENTRIC LTD | N/A | Feb 2026 | 417,101 | NEW | $2.0M | — | 0.04% | EP |
| 45 | ZYMEWORKS DELAWARE INC | 98985Y108 | May 2026 | 47,873 | NEW | $1.2M | — | 0.02% | EC |
| 46 | TUBULIS GMBH | N/A | Feb 2026 | 9,200 | NEW | $982K | — | 0.02% | EC |
| 47 | TUBULIS GMBH | N/A | Feb 2026 | 9,200 | NEW | $647K | — | 0.01% | EC |
| 48 | CYCLERION THERAPEUTICS INC | N/A | Feb 2026 | 246,900 | NEW | $630K | — | 0.01% | EC |
| 49 | SEPTERNA INC | 81734D104 | May 2026 | 19,400 | NEW | $586K | — | 0.01% | EC |
| 50 | TUBULIS GMBH | N/A | Feb 2026 | 9,200 | NEW | $512K | — | 0.01% | EC |
| 51 | BELITE BIO INC | 07782B104 | May 2026 | 3,100 | NEW | $447K | — | 0.01% | EC |
| 52 | INMED PHARMACEUTICALS INC | N/A | Feb 2026 | 191,200 | NEW | $442K | — | 0.01% | EC |
| 53 | KORRO BIO INC | N/A | Feb 2026 | 32,866 | NEW | $441K | — | 0.01% | EC |
| 54 | TUBULIS GMBH | N/A | Feb 2026 | 9,200 | NEW | $440K | — | 0.01% | EC |
| 55 | AVALYN PHARMA INC | 05348Y105 | May 2026 | 15,000 | NEW | $432K | — | 0.01% | EC |
| 56 | ELEVATEBIO, LLC | N/A | Feb 2026 | 216,600 | NEW | $399K | — | 0.01% | EP |
| 57 | FIRST TRACKS BIOTHERAPEUTICS INC | 337185102 | May 2026 | 23,300 | NEW | $372K | — | 0.01% | EC |
| 58 | ANTARES THERAPEUTICS INC | N/A | Feb 2026 | 325,500 | NEW | $296K | — | 0.01% | EC |
| 59 | GENERATE BIOMEDICINE INC | 370920100 | May 2026 | 21,800 | NEW | $286K | — | 0.01% | EC |
| 60 | TUBULIS GMBH | N/A | Feb 2026 | 9,200 | NEW | $270K | — | 0.01% | EC |
| 61 | TUBULIS GMBH | N/A | Feb 2026 | 9,200 | NEW | $263K | — | 0.01% | EC |
| 62 | SEAPORT THERAPEUTICS INC | 81221K108 | May 2026 | 12,700 | NEW | $231K | — | 0.00% | EC |
| 63 | NOVOCURE LTD | N/A | Feb 2026 | 11,113 | NEW | $189K | — | 0.00% | EC |
| 64 | BLUE MARLIN THERAPEUTICS, INC. | N/A | Feb 2026 | 1,636 | NEW | $102K | — | 0.00% | EC |
| 65 | TUBULIS GMBH | N/A | Feb 2026 | 9,200 | NEW | $86K | — | 0.00% | EC |
| 66 | FOGHORN THERAPEUTICS INC | N/A | Feb 2026 | 372,579 | NEW | $73K | — | 0.00% | EC |
| 67 | TUBULIS GMBH | N/A | Feb 2026 | 9,200 | NEW | $43K | — | 0.00% | EC |
| 68 | TUBULIS GMBH | N/A | Feb 2026 | 9,200 | NEW | $43K | — | 0.00% | EC |
| 69 | MYOS CORP | N/A | Feb 2026 | 33,334 | NEW | $42K | — | 0.00% | EC |
| 70 | TUBULIS GMBH | N/A | Feb 2026 | 9,200 | NEW | $32K | — | 0.00% | EC |
| 71 | TUBULIS GMBH | N/A | Feb 2026 | 9,200 | NEW | $20K | — | 0.00% | EC |
| 72 | TUBULIS GMBH | N/A | Feb 2026 | 9,200 | NEW | $19K | — | 0.00% | EC |
| 73 | CYCLERION THERAPEUTICS INC | N/A | Feb 2026 | 4,740 | NEW | $15K | — | 0.00% | EC |
| 74 | FOGHORN THERAPEUTICS INC | N/A | Feb 2026 | 372,579 | NEW | $4K | — | 0.00% | EC |
| 75 | BIOMEA FUSION INC | N/A | Feb 2026 | 46,134 | NEW | $857 | — | 0.00% | EC |
| 76 | TUBULIS GMBH | N/A | Feb 2026 | 9,200 | NEW | $184 | — | 0.00% | EC |
| 77 | AFFERENT PHARMA | N/A | Feb 2026 | 8,274,568 | NEW | $83 | — | 0.00% | EP |
| 78 | SCORPION THERAPEUTICS INC | N/A | Feb 2026 | 5,166,448 | NEW | $52 | — | 0.00% | EC |
| 79 | CHINOOK THERAPEUTICS INC | N/A | Feb 2026 | 115,821 | NEW | $1 | — | 0.00% | EC |
| 80 | MEDAVAIL HOLDINGS INC | N/A | Feb 2026 | 55 | NEW | $0 | — | 0.00% | EC |